1. Home
  2. MXCT vs NCTY Comparison

MXCT vs NCTY Comparison

Compare MXCT & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • NCTY
  • Stock Information
  • Founded
  • MXCT 1999
  • NCTY 1999
  • Country
  • MXCT United States
  • NCTY China
  • Employees
  • MXCT N/A
  • NCTY N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NCTY Business Services
  • Sector
  • MXCT Health Care
  • NCTY Consumer Discretionary
  • Exchange
  • MXCT Nasdaq
  • NCTY Nasdaq
  • Market Cap
  • MXCT 148.2M
  • NCTY 121.2M
  • IPO Year
  • MXCT 2021
  • NCTY 2004
  • Fundamental
  • Price
  • MXCT $1.45
  • NCTY $10.92
  • Analyst Decision
  • MXCT Buy
  • NCTY
  • Analyst Count
  • MXCT 4
  • NCTY 0
  • Target Price
  • MXCT $7.50
  • NCTY N/A
  • AVG Volume (30 Days)
  • MXCT 797.5K
  • NCTY 56.3K
  • Earning Date
  • MXCT 11-05-2025
  • NCTY 01-01-0001
  • Dividend Yield
  • MXCT N/A
  • NCTY N/A
  • EPS Growth
  • MXCT N/A
  • NCTY N/A
  • EPS
  • MXCT N/A
  • NCTY N/A
  • Revenue
  • MXCT $35,754,000.00
  • NCTY $15,305,175.00
  • Revenue This Year
  • MXCT N/A
  • NCTY N/A
  • Revenue Next Year
  • MXCT $14.79
  • NCTY N/A
  • P/E Ratio
  • MXCT N/A
  • NCTY N/A
  • Revenue Growth
  • MXCT N/A
  • NCTY N/A
  • 52 Week Low
  • MXCT $1.26
  • NCTY $6.28
  • 52 Week High
  • MXCT $5.20
  • NCTY $20.59
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 43.25
  • NCTY 65.17
  • Support Level
  • MXCT $1.39
  • NCTY $9.06
  • Resistance Level
  • MXCT $1.49
  • NCTY $10.88
  • Average True Range (ATR)
  • MXCT 0.06
  • NCTY 0.70
  • MACD
  • MXCT 0.04
  • NCTY 0.20
  • Stochastic Oscillator
  • MXCT 76.47
  • NCTY 96.27

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About NCTY The9 Limited American Depository Shares

The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.

Share on Social Networks: